Chemomab Therapeutics (CMMB) Earnings
|
Expand Research on CMMB
| Next EPS Date | 11/6/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +72.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +4.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/6/26  |
Q326 | N/A | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/12/26 |
Q226 | N/A | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/7/26 |
Q226 | N/A | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/19/26 |
Q226 | N/A | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/13/26 |
Q226 | N/A | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/17/26 |
Q226 | N/A | $0.00 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A |
